SYDNEY (Reuters) - An experimental drug developed by an Australian researcher could help prevent deaths from COVID-19 by controlling the formation of blood clots responsible for breathing difficulties, organ failure, stroke and heart attack.
Professor Shaun Jackson from the University of Sydney and the Heart Research Institute is leading a team of researchers developing a new anti-clotting medicine to treat stroke.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
